702 results on '"Fomin, V. V."'
Search Results
152. Hypolipidemic Therapy and Chronic Kidney Disease: Effects on Cardiovascular Risks and Renal Dysfunction
153. The use of telmisartan in patients with refractory arterial hypertension and obesity
154. THE CLINICAL SIGNIFICANCE OF THE DAILY MONITORING OF HOLTER ECG IN CHRONIC GLOMERULONEPHRITIS AT THE PREDIALYSIS STAGE OF THE DISEASE
155. Pentoxifylline and nephroprotection: effects on renal dysfunction and cardiovascular risks
156. Correlations between parameters of central hemodynamics and cytokine profile in chronic kidney disease in combination with cerebrovascular diseases
157. Prevention of thromboembolic and hemorrhagic events in patients with atrial fibrillation undergoing elective surgery
158. Effective decrease of radioactive inert gas emissions from nuclear power plants with RBMK reactors
159. CLINICAL IMPORTANCE OF MARKERS OF RENAL DYSFUNCTION IN CARDIO-VASCULAR RISK STRATIFICATION
160. Treatment of hypertension in obese patients: focus on telmisartan
161. Cornea verticillata in Fabry disease
162. STRATIFICATION OF NEPHROCEREBRAL AND CARDIOVASCULAR RISK IN CHRONIC GLOMERULONEPHRITIS (LITERATURE REVIEW)
163. MULTISLICE COMPUTED TOMOGRAPHY TO MEASURE VISCERAL FAT AREA IN PATIENT WITH ASTHMA AND OBESITY
164. Quantitative evaluation of DNA single-strand breaks in irradiated P-388 leukemia cells using the method of alkaline denaturation
165. The Effectiveness Analysis Of Medical Care Management In The Regional Vascular Center For Patients Of Elderly And Senile Age With Acute Myocardial Infarction.
166. Historical Avenues of Research in Russian Forest Typology: Ecological, Phytocoenotic, Genetic, and Dynamic Classifications
167. Interstitial pulmonary fibrosis: The role of angiogenic factors, the inhibitory pathways of progression
168. Bilateral thalamic stroke in patient with patent foramen ovale and hereditary thrombophilia
169. Clinical Case: Tuberculous Myopericarditis in the Cardiology Practice
170. From Schönlein-Henoch purpura to IgA-vasculitis: pathogenetic aspects of the disease
171. Inflammation in chronic kidney disease: sources, consequences and anti-inflammatory therapy.
172. Arterial hypertension at the workplace: risk factors and the population value
173. Renal denervation with a resistant arterial hypertension: the results of a five-year follow-up
174. Influence of a Vertical Shift in the Current Velocity during Propagation of Contaminated Water from an Underwater Outfall under Stratified Conditions
175. Variety of lung involvement in autoimmune liver diseases
176. Inhibition of HIF-prolyl 4-hydroxylases as a promising approach to the therapy of cardiometabolic diseases
177. ACUTE DECOMPENSATION OF HYPERTENSIVE HEART DISEASE IN PATIENT WITH MALIGNANT URINARY BLADDER PARAGANGLIOMA: STAGES OF DIAGNOSTICS AND TREATMENT
178. THROMBOSIS OF LEFT ATRIAL APPENDAGE DURING THERAPY WITH DIRECT ORAL ANTICOAGULANT. CLINICAL CASE
179. COMPARISON OF SCHEMES OF PERIOPERATIONAL ANTICOAGULATION IN ATRIAL FIBRILLATION PATIENTS DEMANDING FOR SURGERY
180. Fibroblast growth factor-23 (FGF-23) / soluble Klotho protein (sKlotho) / sclerostin glycoprotein ratio disturbance is a novel risk factor for cardiovascular complications in ESRD patients receiving treatment with regular hemodialysis or hemodiafiltration
181. Management of chronic kidney disease in the Russian Federation: A critical review of prevalence and preventive programmes
182. Ultrasound examination with contrast in the diagnosis of inflammatory bowel disease. The results of the pilot study
183. Evaluation of nephrocerebral risk with the use of cystatin C in patients with chronic kidney disease
184. MicroRNA in ischemic stroke
185. The new 2017 European society of cardiology (ESC) guidelines: important changes for introduction into clinical practice
186. Anticoagulant therapy in patients with atrial fibrillation and reduced kidney function of diabetic and non-diabetic etiologies
187. Teaching therapeutic disciplines: vectors of modernization
188. Loop diuretics in the treatment of edema: torasemide potentials
189. Endothelial dysfunction and arterial wall stiffness: New targets in diabetic nephropathy
190. Numerical modeling of wind waves in the Black Sea generated by atmospheric cyclones
191. Liver diseases: The pathogenetic role of the gut microbiome and the potential of treatment for its modulation
192. Giant cell arteritis: Genetic and epigenetic aspects
193. Evaluation of cardiovascular risks with the use of morphogenetic Klotho protein in patients with chronic renal disease
194. CALCULATION AND ANALYSIS OF THE EXPECTED IMPACT OF THE HYDROTECHNICAL CONSTRUCTION ON THE ENVIRONMENTAL CONDITION IN THE WATER AREA AND BOTTOM TOPOGRAPHY IN CASE OF THE CONSTRUCTION OF THE APPROACH CHANNEL TO THE SABETTA PORT
195. Direct oral anticoagulants in atrial fibrillation patients aged 75 years or older: Efficacy and safety balance
196. Chronic kidney disease and cardiovascular events: a focus on central blood pressure
197. Gender features of cardiovascular events in patients with chronic glomerulonephritis at the pre-dialysis stage of the disease
198. DATA OF CLINICAL PRACTICE AS A TOOL FOR CHOICE OF DIRECT ORAL ANTICOAGULANT
199. BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL
200. Risk factors for anemia in the early stages of chronic kidney disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.